Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica K Altman

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Oncotarget|September 17, 2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemiasDany A Curi, Elspeth M Beauchamp, Gavin T Blyth, et al.
European Journal of Haematology|March 28, 2025
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult PatientsHamza Tariq, Margarita Loxas, Mir B Alikhan, et al.
Haematologica|December 2, 2021
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemiaSumithira Vasu, Jessica K Altman, Geoffrey L Uy, et al.
Blood|March 20, 2013
Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursorsJessica K Altman, Amy Szilard, Bruce W Konicek, et al.
The Journal of Biological Chemistry|February 27, 2008
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2Blazej Dolniak, Efstratios Katsoulidis, Nathalie Carayol, et al.
Human Pathology|May 25, 2019
An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experienceNina Rahimi, Yanming Zhang, Alain Mina, et al.
Oncotarget|March 24, 2016
Repurposing metformin for cancer treatment: current clinical studiesYoung Kwang Chae, Ayush Arya, Mary-Kate Malecek, et al.
The Journal of Biological Chemistry|December 1, 2007
Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responsesJessica K Altman, Patrick Yoon, Efstratios Katsoulidis, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Oncotarget|September 17, 2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemiasDany A Curi, Elspeth M Beauchamp, Gavin T Blyth, et al.
European Journal of Haematology|March 28, 2025
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult PatientsHamza Tariq, Margarita Loxas, Mir B Alikhan, et al.
Haematologica|December 2, 2021
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemiaSumithira Vasu, Jessica K Altman, Geoffrey L Uy, et al.
Blood|March 20, 2013
Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursorsJessica K Altman, Amy Szilard, Bruce W Konicek, et al.
The Journal of Biological Chemistry|February 27, 2008
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2Blazej Dolniak, Efstratios Katsoulidis, Nathalie Carayol, et al.
Human Pathology|May 25, 2019
An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experienceNina Rahimi, Yanming Zhang, Alain Mina, et al.
Oncotarget|March 24, 2016
Repurposing metformin for cancer treatment: current clinical studiesYoung Kwang Chae, Ayush Arya, Mary-Kate Malecek, et al.
The Journal of Biological Chemistry|December 1, 2007
Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responsesJessica K Altman, Patrick Yoon, Efstratios Katsoulidis, et al.
Pageof 17